STI Foundation

PulseWave aims to become a digital health care company redefining the way arterial sclerosis is clinically diagnosed and monitored over time. PulseWave’s development, the TempleGuard combines a wearable biosensor device worn conveniently and permanently with patients Eyeglasses and cloud-based data analytics with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. PulseWave believes improvements in arterial stiffness monitoring and characterization have the potential to change clinical Management of patients.

The support of STI is essential to fund operations, expand Pulsewaves IP footprint and to continue our R&D efforts.